血液ガスおよび電解質分析装置の世界市場規模：製品タイプ別、モダリティ別、用途別、地域別、範囲および予測

血液ガスおよび電解質分析装置の市場規模と予測

血液ガスおよび電解質分析装置市場規模は、2024年に45億5,000万米ドルと評価され、2026年から2032年にかけてCAGR 6.88%で成長し、2032年には77億5,000万米ドルに達すると予測されます。

血液ガスおよび電解質分析装置は、血液中のガスと電解質の濃度を検査する医療機器であり、様々な健康問題の診断と治療に不可欠です。血液ガスには通常、酸素（O2）と二酸化炭素（CO2）が含まれており、肺の働きや酸素が全身にどれだけ効率よく供給されるかを判断するのに重要です。

血液ガスおよび電解質分析装置は、血液サンプルを分析し、さまざまな健康問題を診断・管理するための重要な医療機器です。これらの分析装置は、主に救急医療や救命医療の現場で使用されています。pH、CO2、O2、ナトリウム、カリウム、塩化物など、重要な血液パラメータを迅速かつ正確に評価します。

血液ガス・電解質分析計の将来は、より使いやすく、アクセスしやすくする技術開発が期待されます。ポータブルでコンパクトな分析装置はますます普及し、ヘルスケアプロバイダーは遠方や十分なサービスを受けていない場所を含むさまざまな環境で検査を実施できるようになると思われます。

血液ガスおよび電解質分析装置の世界市場力学

主な市場促進要因

慢性疾患の有病率の上昇：糖尿病、呼吸器疾患、腎臓病などの慢性疾患の有病率の上昇は、血液ガスおよび電解質分析装置市場の主な促進要因です。これらの疾患では、治療管理や合併症予防のために定期的な血液ガス・電解質モニタリングが頻繁に必要となります。世界人口の高齢化と生活習慣病の流行に伴い、これらの要因を正確かつ頻繁に評価する必要性が高まっています。

技術革新：技術革新が血液ガスおよび電解質分析装置業界を大きく押し上げています。ポータブル分析装置や自動分析装置は、検査の効率と精度を向上させる技術革新の一例です。最新の分析装置には、迅速な検査結果、使いやすさ、電子カルテ（EHR）システムとの連動といった特徴があります。これらの機能強化は、患者の治療の質を向上させるだけでなく、検査手順を簡素化します。

ポイントオブケア検査への注目の高まり：ポイント・オブ・ケア（POC）検査がますます重視されるようになっています。ポイント・オブ・ケア検査とは、患者の治療現場またはその近くで行われる診断検査を指します。血液ガスおよび電解質分析装置は、救急部、集中治療室（ICU）、その他迅速で正確な結果を必要とする臨床現場で広く採用されています。POC検査は即座の意思決定と迅速な治療を可能にし、重篤な病態において非常に有用です。

主な課題

精度と校正の問題：血液ガスおよび電解質分析装置の精度を維持することは大きな課題です。安定した結果を得るためには、これらの機器を正確に校正する必要があります。温度変化、湿度、試薬の経年変化はすべて校正に影響を与えます。エラーを避けるためには、定期的な再校正と品質管理検査が必要ですが、これらの作業には時間とコストがかかります。

複雑なメンテナンスと維持管理：血液ガスおよび電解質分析装置が適切に作動するには、頻繁なメンテナンスが必要です。これには洗浄、部品の交換、ソフトウェアの更新などが含まれます。このような保守作業は複雑であるため、特に医療従事者の時間や経験が限られている多忙な医療環境では困難な場合があります。適切なメンテナンスは、機器の故障を防ぎ、分析装置が正確で一貫した結果を出すために非常に重要です。

機器と消耗品の初期費用が高い：血液ガス分析装置や電解質分析装置の購入は、医療施設によっては、特に資源が限られている状況では、法外に高価な場合があります。さらに、これらの装置は試薬や校正液などの特殊な消耗品を必要とするため、コストがかかります。これらの消耗品にかかる定期的なコストは、分析装置を使用する際の経済的負担を増大させる。

主要動向：

電子カルテ（EHR）との統合：血液ガス分析装置や電解質分析装置とEHRシステムを統合する傾向が強まっています。このインターフェースにより、シームレスなデータ転送と患者情報のリアルタイム修正が可能になります。手入力のミスが減り、ヘルスケア・プロバイダーが検査結果をすぐに利用できるようになります。

ポータブル・ポイントオブケア機器の進歩：ポータブルおよびポイントオブケア（POC）血液ガスおよび電解質分析装置の使用が増加しています。これらの装置は、患者のいる場所やその近くで検査ができるという利点があり、緊急時や中央検査室へのアクセスが制限されている地域では特に有益です。最近の改良により、これらの機器はよりコンパクトで使いやすくなり、より迅速な結果やマルチパラメータ検査などの新しい機能を備えた精密なものとなっています。

精度と信頼性の向上：血液ガスおよび電解質分析装置の精度と信頼性の向上がより重視されています。改良されたセンサー技術や優れた校正プロセスなどの技術の進歩は、結果が常に正確で信頼できることを保証するために適用されています。治療メーカーは、血液中の他の薬物による干渉やサンプル処理の違いなど、不正確さの潜在的な原因を減らす努力をしています。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 血液ガスおよび電解質分析装置市場：製品タイプ別

• 血液ガス分析装置
• 電解質分析装置

第5章 血液ガスおよび電解質分析装置市場：モダリティ別

• ポータブル分析装置
• ベンチトップ/ベッドサイド型分析装置

第6章 血液ガスおよび電解質分析装置市場：用途別

• クリティカルケア
• ラボ

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Abbott Laboratories
• Danaher Corporation（Radiometer）
• F. Hoffmann-La Roche AG
• IDEXX Laboratories, Inc.（Opti Medical Systems, Inc.）
• Medica Corporation
• Nova Biomedical
• Sensa Core Medical Instrumentation Pvt. Ltd.
• Siemens Healthineers（Siemens AG）
• Transasia Bio-Medicals Ltd.（Erba Diagnostics Mannheim Gmbh）
• Werfen Science SA

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Blood Gas and Electrolyte Analyzers Market Size and Forecast

Blood Gas and Electrolyte Analyzers Market size was valued at USD 4.55 Billion in 2024 and is projected to reach USD 7.75 Billion by 2032, growing at a CAGR of 6.88% from 2026 to 2032.

Blood gas and electrolyte analyzers are medical equipment that tests the levels of gases and electrolytes in the blood which is essential for diagnosing and treating a variety of health issues. Blood gases typically contain oxygen (O2) and carbon dioxide (CO2) which are important for determining how well the lungs work and how efficiently oxygen is delivered throughout the body.

Blood gas and electrolyte analyzers are critical medical instruments that analyze blood samples to diagnose and manage a wide range of health issues. These analyzers are mostly used in emergency and critical care settings. They assess vital blood parameters quickly and accurately including pH, CO2, O2, sodium, potassium, and chloride.

The future of blood gas and electrolyte analyzers is expected to witness technological developments that make them more user-friendly and accessible. Portable and compact versions of these analyzers are likely to become increasingly prevalent allowing healthcare providers to perform tests in a variety of settings including distant or underserved places.

Global Blood Gas and Electrolyte Analyzers Market Dynamics

The key market dynamics that are shaping the global blood gas and electrolyte analyzers market include:

Key Market Drivers:

Rising Prevalence of Chronic Diseases: The rising prevalence of chronic ailments such as diabetes, respiratory problems, and kidney disease is a primary driver of the blood gas and electrolyte analyzers market. These disorders frequently necessitate regular blood gas and electrolyte monitoring to manage treatment and prevent complications. As the world population ages and lifestyle-related diseases become more prevalent, there is a greater need for precise and frequent assessment of these factors.

Innovations in Technology: Technological innovations are majorly boosting the blood gas and electrolyte analyzer industry. Portable and automated analyzers are examples of innovations that improve testing efficiency and accuracy. Modern analyzers include features such as fast test results, ease of use, and interaction with electronic health record (EHR) systems. These enhancements not only improve the quality of patient treatment but also simplify laboratory procedures.

Increasing Focus on Point-of-Care Testing: There is an increasing emphasis on point-of-care (POC) testing which refers to diagnostic testing performed at or near the site of patient care. Blood gas and electrolyte analyzers are widely employed in emergency departments, intensive care units (ICUs), and other clinical settings that require quick and precise results. POC testing enables immediate decision-making and faster treatment which is very useful in critical care conditions.

Key Challenges:

Accuracy and Calibration Issues: Keeping blood gas and electrolyte analyzers accurate is a major difficulty. These devices must be accurately calibrated to get consistent results. Temperature changes, humidity, and reagent age all have an impact on calibration. To avoid errors, regular recalibration and quality control inspections are required; however, these operations can be time-consuming and costly.

Complex Maintenance and Upkeep: Blood gas and electrolyte analyzers require frequent maintenance to perform properly. This includes cleaning, changing components, and updating software. The complexity of these maintenance activities can be difficult, particularly in busy healthcare environments where workers may have limited time and experience. Proper maintenance is critical for avoiding equipment failures and ensuring that analyzers produce accurate and consistent results.

High Initial Cost of Equipment and Consumables: Purchasing blood gas and electrolyte analyzers might be prohibitively expensive for some healthcare facilities, especially in resource-constrained situations. Furthermore, these devices require specialized consumables such as reagents and calibration solutions which can be costly. The recurring costs of these consumables increase the financial burden of using these analyzers.

Key Trends:

Integration with Electronic Health Records (EHRs): There is an increasing trend of combining blood gas and electrolyte analyzers with EHR systems. This interface enables seamless data transfer and real-time modifications to patient information. It reduces manual entry errors and guarantees that test findings are readily available to healthcare providers.

Advancements in Portable and Point-Of-Care Devices: Portable and point-of-care (POC) blood gas and electrolyte analyzers are increasingly used. These devices provide the advantage of doing tests at or near the patient's location which is especially beneficial in emergencies or areas with restricted access to central laboratories. Recent improvements have made these devices more compact, user-friendly, and precise with new capabilities like faster results and multi-parameter testing.

Increased Focus on Accuracy and Reliability: There is a greater emphasis on enhancing the accuracy and reliability of blood gas and electrolyte analyzers. Advances in technology such as improved sensor technologies and superior calibration processes are being applied to ensure that results are consistently exact and reliable. Manufacturers are working to reduce potential sources of inaccuracy such as interference from other drugs in the blood or differences in sample treatment.

Global Blood Gas and Electrolyte Analyzers Market Regional Analysis

Here is a more detailed regional analysis of the global blood gas and electrolyte analyzers market:

North America:

The North American blood gas and electrolyte analyzers market is primarily driven by the rising prevalence of chronic diseases and the aging population. The United States, in particular, dominates this regional market because of its advanced healthcare infrastructure and high healthcare spending. The rising prevalence of chronic respiratory disorders is a major driving force in the North American blood gas and electrolyte analyzers market. The Centers for Disease Control and Prevention (CDC) estimates that approximately 16 million Americans suffer from chronic obstructive pulmonary disease (COPD). According to the CDC, asthma affects around 25 million Americans, or one in every thirteen individuals.

Furthermore, the National Heart, Lung, and Blood Institute estimates that approximately 6.2 million adults in the United States have heart failure, a condition that frequently requires blood gas analysis for effective care. The elderly population in North America also makes a substantial contribution to market growth. According to the United States Census Bureau, by 2030, all baby boomers will be over the age of 65, bringing the total elder population to 73 million people.

Asia Pacific:

The Asia Pacific region is seeing the highest growth in the blood gas and electrolyte analyzers market owing to rapid healthcare infrastructure development and rising awareness of the need for critical care testing. The region's aging population and increased prevalence of chronic diseases have hastened this growth. The rising prevalence of chronic respiratory disorders is a major driving force in the Asia Pacific blood gas and electrolyte analyzers market. According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) causes 3 million fatalities per year worldwide with the Western Pacific Region which includes many Asian countries accounting for 38.6% of these deaths.

According to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), the number of elderly people (aged 65 and more) in Asia and the Pacific is predicted to more than double from 612 million in 2022 to around 1.3 billion in 2050. This demographic shift is projected to boost demand for critical care services including blood gas and electrolyte analysis. Furthermore, the rapid expansion of healthcare infrastructure in developing Asian countries is driving market growth.

Global Blood Gas and Electrolyte Analyzers Market: Segmentation Analysis

The Global Blood Gas and Electrolyte Analyzers Market is segmented based on Product Type, Modality, Application, and Geography.

Blood Gas and Electrolyte Analyzers Market, By Product Type

• Blood Gas Analyzers
• Electrolyte Analyzers

Based on the Product Type, the Global Blood Gas and Electrolyte Analyzers Market is bifurcated into Blood Gas Analyzers and Electrolyte Analyzers. In the global blood gas and electrolyte analyzers market, blood gas analyzers are currently dominant over electrolyte analyzers. This dominance is driven by the critical role blood gas analyzers play in assessing a patient's respiratory function, acid-base balance, and overall metabolic state which are crucial for managing conditions in emergency care and intensive care units. These analyzers provide comprehensive real-time data on parameters such as pH, pCO2, and pO2 which are essential for accurate diagnosis and treatment decisions.

Blood Gas and Electrolyte Analyzers Market, By Modality

• Portable Analyzers
• Benchtop/Bedside Analyzers

Based on the Modality, the Global Blood Gas and Electrolyte Analyzers Market is bifurcated into Portable Analyzers and Benchtop/Bedside Analyzers. In the global blood gas and electrolyte analyzers market, benchtop/bedside analyzers are currently dominant. These analyzers are preferred due to their high accuracy, reliability, and ability to handle a broad range of tests simultaneously making them ideal for hospital settings and critical care units. They offer advanced features such as multiple parameter analysis and robust performance which are crucial for comprehensive diagnostic needs.

Blood Gas and Electrolyte Analyzers Market, By Application

• Critical Care Settings
• Laboratories

Based on the Application, the Global Blood Gas and Electrolyte Analyzers Market is bifurcated into Critical Care Settings and Laboratories. In the global blood gas and electrolyte analyzers market, critical care settings dominate over laboratories. This dominance is primarily driven by the urgent need for rapid and accurate monitoring of blood gas and electrolyte levels in critically ill patients. Critical care environments such as intensive care units (ICUs) and emergency departments require continuous or frequent testing to manage complex and dynamic patient conditions effectively. These settings demand real-time, precise data to guide immediate treatment decisions which drives a higher demand for advanced blood gas and electrolyte analyzers.

Blood Gas and Electrolyte Analyzers Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Blood Gas and Electrolyte Analyzers Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the global blood gas and electrolyte analyzers market. This dominance is largely due to the region's advanced healthcare infrastructure, high adoption rate of cutting-edge medical technologies, and significant investments in research and development. North America's well-established healthcare systems including numerous hospitals and diagnostic centers drive the demand for sophisticated diagnostic equipment.

Key Players

The "Global Blood Gas and Electrolyte Analyzers Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche AG, IDEXX Laboratories, Inc., Medica Corporation, Nova Biomedical, Sensa Core Medical Instrumentation Pvt. Ltd., Siemens Healthineers, Transasia Bio-Medicals Ltd., and Werfen Science SA.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Blood Gas and Electrolyte Analyzers Market Key Developments

• In May 2024, Radiometer collaborated with Etiometry to improve workflow and clinical decision-making in hospitals and healthcare facilities. This collaboration will combine Radiometer's acute care diagnostics with the Etiometry platform to improve blood gas analysis in critical care settings.
• In June 2023, B&E BIO-TECHNOLOGY CO., LTD. announced the release of the Check handheld blood gas electrolyte to help improve and advance point-of-care testing capabilities.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Blood Gas And Electrolyte Analyzers Market, By Product Type

• Blood Gas Analyzers
• Electrolyte Analyzers

5. Blood Gas And Electrolyte Analyzers Market, By Modality

• Portable Analyzers
• Benchtop/Bedside Analyzers

6. Blood Gas And Electrolyte Analyzers Market, By Application

• Critical Care Settings
• Laboratories

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Abbott Laboratories
• Danaher Corporation (Radiometer)
• F. Hoffmann-La Roche AG
• IDEXX Laboratories, Inc. (Opti Medical Systems, Inc.)
• Medica Corporation
• Nova Biomedical
• Sensa Core Medical Instrumentation Pvt. Ltd.
• Siemens Healthineers (Siemens AG)
• Transasia Bio-Medicals Ltd. (Erba Diagnostics Mannheim Gmbh)
• Werfen Science SA

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References